L48. The challenges in assessing Takayasu arteritis

Presse Med. 2013 Apr;42(4 Pt 2):634-5. doi: 10.1016/j.lpm.2013.01.044. Epub 2013 Mar 9.

Authors

Paul Bacon¹, Ramnath Misra

Affiliation

¹ University of Birmingham, Birmingham, UK. p.a.bacon@bham.ac.uk

PMID: 23477714
DOI: 10.1016/j.lpm.2013.01.044

No abstract available

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Blood Sedimentation
C-Reactive Protein / analysis
Combined Modality Therapy
Diagnostic Imaging
Disease Progression
Drug Therapy, Combination
Endovascular Procedures
Humans
Immunosuppressive Agents / therapeutic use
Ischemia / classification
Ischemia / diagnosis
Ischemia / therapy
Prognosis
Recurrence
Stents
Takayasu Arteritis / classification
Takayasu Arteritis / diagnosis*
Takayasu Arteritis / therapy

Substances

Adrenal Cortex Hormones
Immunosuppressive Agents
C-Reactive Protein